Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study.
Gérard de PouvourvilleDavid CunninghamFrank-Ulrich FrickePeter LindgrenLorenzo MantovaniLinda A MurphyOriol Solà-MoralesJorge Mestre-FerrandizRon AkehurstPublished in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2023)
A continuous investment in national health information systems is a key issue for providing valid RWE. Processes and aids to guide the acceptability and usage of RWE derived from pairing between sources and questions are essential.